Pocket Book of Hospital Care for Children
Pocket Book of Hospital Care for Children

Author: World Health Organization

Publisher: World Health Organization

Published: 2013

Total Pages: 442

ISBN-13: 9241548371

DOWNLOAD EBOOK

The Pocket Book is for use by doctors nurses and other health workers who are responsible for the care of young children at the first level referral hospitals. This second edition is based on evidence from several WHO updated and published clinical guidelines. It is for use in both inpatient and outpatient care in small hospitals with basic laboratory facilities and essential medicines. In some settings these guidelines can be used in any facilities where sick children are admitted for inpatient care. The Pocket Book is one of a series of documents and tools that support the Integrated Managem.

Fundamentals of Pediatric Drug Dosing
Fundamentals of Pediatric Drug Dosing

Author: Iftekhar Mahmood

Publisher: Springer

Published: 2016-10-28

Total Pages: 149

ISBN-13: 3319437542

DOWNLOAD EBOOK

Focused on pediatric physiology, pharmacology, pharmacokinetics and pharmacodynamics, this book illustrates the differences between the pediatric population and adults; knowledge of extreme importance not only during pediatric drug development but also in the clinical practice. Physicians, nurses, clinical pharmacologists, researchers and healthcare professionals will find this an invaluable resource. With the advent of pediatric exclusivity, and requirements to conduct clinical studies in children, an emphasis has been placed on finding a safe and efficacious dose of a drug in children. Children are not ‘small adults’, and drug dosing in this population requires special consideration. There are subtle physiological and biochemical differences among neonates, infants, children, adolescents and adults and dosing in pediatrics requires proper understanding of these factors. Furthermore, dosing in children, as in adults, should be based on pharmacokinetic and pharmacodynamic data. This is an evolving area, as pediatric pharmacokinetic studies are becoming mandatory for getting approval of new drugs in this population.

Drug Dosages in Children
Drug Dosages in Children

Author: Meharban Singh

Publisher: CBS Publishers & Distributors Pvt Limited, India

Published: 2019-05-30

Total Pages:

ISBN-13: 9789388902663

DOWNLOAD EBOOK

Serves as a ready-reckoner of drug dosages for young residents and practising pediatricians which will instil confidence in their prescribing abilities and reduce the incidence of avoidable side effects of drugs. It provides brief Information on the pharmacokinetics of drugs with an emphasis on the advantages and disadvantages of various routes of administration, drug absorption, distribution, bioavailabillty, tissue binding, half-life and metabolism and excretion. The drugs have been listed alphabetically with dally dosages per unit body weight, frequency, and route of administration. Important cautions, contraindications and adverse effects of selected drugs have been provided. Trade names of formulations from standard pharmaceutical companies along with their products and strengths are also given.

Safe and Effective Medicines for Children
Safe and Effective Medicines for Children

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2012-10-13

Total Pages: 432

ISBN-13: 0309225493

DOWNLOAD EBOOK

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.

Manual of Childhood Infections
Manual of Childhood Infections

Author: Mike Sharland

Publisher: Oxford University Press, USA

Published: 2011-04-07

Total Pages: 913

ISBN-13: 0199573581

DOWNLOAD EBOOK

This manual gives information on the causative organisms, epidemiology and clinical features of all important childhood infections. It includes guidance on the clinical management of the infections and on steps to be taken to prevent future cases.

Rational Therapeutics for Infants and Children
Rational Therapeutics for Infants and Children

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2000-04-07

Total Pages: 135

ISBN-13: 0309183642

DOWNLOAD EBOOK

The Institute of Medicine's (IOM's) Roundtable on Research and Development of Drugs, Biologics, and Medical Devices evolved from the Forum on Drug Development, which was established in 1986. Sponsor representatives and IOM determined the importance of maintaining a neutral setting for discussions regarding long-term and politically sensitive issues justified the need to revise and enhance past efforts. The new Roundtable is intended to be a mechanism by which a broad group of experts from the public* and private sectors can be convened to conduct a dialogue and exchange information related to the development of drugs, biologics, and medical devices. Members have expertise in clinical medicine, pediatrics, clinical pharmacology, health policy, health insurance, industrial management, and product development; and they represent interests that address all facets of public policy issues. From time to time, the Roundtable requests that a workshop be conducted for the purpose of exploring a specific topic in detail and obtaining the views of additional experts. The first workshop for the Roundtable was held on April 14 and 15, 1998, and was entitled Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making. The summary on that workshop is available from IOM. This workshop summary covers the second workshop, which was held on May 24 and 25, 1999, and which was aimed at facilitating the development and proper use of drugs, biologics, and medical devices for infants and children. It explores the scientific underpinnings and clinical needs, as well as the regulatory, legal, and ethical issues, raised by this area of research and development.